No Data
No Data
Willow Biosciences CEO Confident in Future After Record Revenue and New Partnerships - ICYMI | TSX:WLLW, OTCQB:CANSF
Willow Biosciences Reports Record Revenue Growth and Strategic Advances in Q2 2024 | TSX:WLLW, OTCQB:CANSF
Press Release: WILLOW BIOSCIENCES REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
WILLOW BIOSCIENCES ANNOUNCES NEW FUNDED BIOPESTICIDES RESEARCH AND DEVELOPMENT PARTNERSHIP AFTER SUCCESSFULLY COMPLETING FEASIBILITY STUDY
Willow Biosciences Projecting Over $1M in 2Q Revenue | TSX:WLLW, OTCQB:CANSF
Willow Biosciences Brief: Announced Multi-product Development and Licensing Partnership With Laurus Labs for Manufacturing Active Pharmaceutical Ingredients